Monte H. Moore, MD. Idaho Physical Medicine and Rehabilitation. Meridian, ID

Similar documents
Opioids in the Management of Chronic Pain: An Overview

SUMMARY OF ARIZONA OPIOID PRESCRIBING GUIDELINES FOR THE TREATMENT OF CHRONIC NON-TERMINAL PAIN (CNTP)

Managing the Chronic Pain Patient. (and some stuff about opioids)

Treating Pain and Depression

Neuropathic Pain and Pain Management Options. Mihnea Dumitrescu, MD

Nociceptive Pain. Pathophysiologic Pain. Types of Pain. At Presentation. At Presentation. Nonpharmacologic Therapy. Modulation

If Not Opioids then LEAH EDMONDS CSHP OCTOBER 26, 2017

solutions MEDICATION MIS MANAGEMENT and Chronic Pain 10/4/2016 Opioid Abuse: Current Data Opioid Abuse: Current Data

Subject: Pain Management (Page 1 of 7)

An unpleasant sensory and emotional experience associated with actual or potential tissue damage.

Knock Out Opioid Abuse in New Jersey:

POST OPERATIVE PAIN MANAGEMENT: PAIN AND COMPLICATIONS

Opioid Analgesics: Responsible Prescribing in the Midst of an Epidemic

Medications for the Treatment of Neuropathic Pain

OPIOIDS FOR PERSISTENT PAIN: INFORMATION FOR PATIENTS

Chronic Pain: Advances in Psychotherapy

A Patient s Guide to The Medication Approach to Chronic Pain

9/30/2017. Case Study: Complete Pain Assessment and Multimodal Approach to Pain Management. Program Objectives. Impact of Poorly Managed Pain

Colorado State Board of Medical Examiners Policy

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

Understanding pain and mental illness Impact on management principles

Recognizing Narcotic Abuse and Addiction and Helping Those With It

Practical Pain Management Leah Centanni, MSN, FNP-C, Asst. Clinical Professor CANP Conference March 22, 2014

Pain CONCERN. Medicines for long-term pain. Antidepressants

CHAPTER 4 PAIN AND ITS MANAGEMENT

PAIN TERMINOLOGY TABLE

Canadian Guideline for Opioids for Chronic Non-Cancer Pain. Speaker Disclosure. Objectives. Canadian Guideline for Opioids for Chronic Non-Cancer Pain

Headaches, 37, 42 Hypnotherapy, 101t, 106 Hypothalamic-pituitary-adrenal (HPA) axis, 59, 61, 63, 64, 65

Proposed Revision to Med (i)

IMPROVING CHRONIC PAIN PATIENTS QUALITY OF LIFE WITH CUTTING EDGE TECHNOLOGY. Jacqueline Weisbein, DO Napa Valley Orthopaedic Medical Group

HOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain

No Pain, No Gain Pharmacy Patient Pain Counseling Competition

No disclosures for any of the speakers!

MANAGEMENT OF VISCERAL PAIN

Rational Polypharmacy

Neuropathic Pain in Palliative Care

3/3/2015 CHRONIC PAIN MARGARET ZOELLERS, MSN, APRN

Describe Identify Compare Recognize

Hospital Based Opioid Management A case based, peer discussion

Tips for Pain Management

Neuropathic pain (pain due to nerve damage)

Non-Opioid Drugs to Treat Neuropathic Pain. March 2018

D. Janene Holladay, M.D. Board Certifications: American Board of Anesthesiology American Board of Pain Medicine American Board of Addiction Medicine

Neuropathic Pain Treatment Guidelines

Where is your pain located? Please use the diagram below to indicate where most of your pain is located.

Chronic Pain Pharmacist role in the clinic

Opioid Analgesic Treatment Worksheet

I. Chronic Pain Information Page 2-3. II. The Role of the Primary Care Physician in Chronic Pain Management Page 3-4

IEHP UM Subcommittee Approved Authorization Guidelines Referrals to Pain Management Specialists

HealthPartners Inspire Special Needs Basic Care Clinical Care Planning and Resource Guide CHRONIC PAIN

Missouri Guidelines for the Use of Controlled Substances for the Treatment of Pain

1) On a scale of 1 10, how would you rate your pain Most of the time, 0 being pain free and 10 being most severe?

Syllabus. Questions may appear on any of the topics below: I. Multidimensional Nature of Pain

Antidepressant Medication Therapy in Primary Care July 25, 2013

Adult Health History Form Preferred Name: 1

IF I M NOT TREATING WITH OPIOIDS, THEN WHAT AM I SUPPOSED TO USE?

Choose a category. You will be given the answer. You must give the correct question. Click to begin.

PAIN MANAGEMENT & MAXIMIZING QUALITY OF LIFE DURING TREATMENT

Responding to The Joint Commission Alert on Safe Use of Opioids in Hospitals

KANSAS Kansas State Board of Healing Arts. Source: Kansas State Board of Healing Arts. Approved: October 17, 1998

Making sense of fibromyalgia syndrome. Charles Radis D.O. Clinical Professor of Medicine UNECOM

What is pregabalin? Pregabalin tablets. Pregabalin misuse. National Drug Treatment Centre Research. Administration

Conflicts of Interests: None

The Use of Antidepressants in the Treatment of Irritable Bowel Syndrome and Other Functional GI Disorders What are functional GI disorders?

Treatment of Neuropathic Pain: What Does the Evidence Say? or Just the Facts Ma am

Based on Tip 54. Managing Chronic Pain in Adults With or in Recovery From Substance Use Disorders KAP KEYS FOR CLINICIANS

Opioids: Use, Abuse and Cause of Death. Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory

Legacy Pain Management Center New Patient Questionnaire

Overview of Neuropathic pain

Disclosures. Management of Chronic, Non- Terminal Pain. Learning Objectives. Outline. Drug Schedules. Applicable State Laws

FIBROMYALGIA. Raj Saini Greenbrook Pharmacy

CHRONIC PELVIC PAIN AS WE UNDERSTAND IT TODAY. Dr. Sonia Wartan Consultant in Pain Medicine

Analgesia in patients with impaired renal function Formulary Guidance

Risk Reduction Strategies in Pain Management

Opiate Use Disorder and Opiate Overdose

Acute pain management in opioid tolerant patients. Muhammad Laklouk

Pain Signaling Neuropathic Pain Distinctly different from nociceptive pain Sustained by abnormal processing of sensory input by the peripheral or cent

Pain Assessment & Management. For General Nursing Orientation

Fibromyalgia: are you a believer?

NBPDP Drug Utilization Review Process Update

Pain 101: An Introduction to Chronic Pain & Pain Management

Opioid Analgesic Treatment Worksheet

Clinical and Contextual Evidence Reviews

IEHP UM Subcommittee Approved Authorization Guidelines Referrals to Pain Management Specialists

Disclosures & Warnings

Opioids in Pain and Addiction

Summary of Pain Management Issues

H NDS-ONHealth. Prescription Drug Abuse. Drug overdose death rates in the United States have more than tripled since 1990 and have never been higher.

MAT for Opioid Dependence. MAT and Pain Management. Epidemiology. Epidemiology. Factors Impacting Pain Perception 9/23/2014

3/7/2018. IASP updated definition of pain. Nociceptive Pain. Transduction. (Nociceptors) Transmission. (Peripheral nerve) Modulation

Steven Prakken MD Chief, Medical Pain Service Duke Pain Medicine

Pain Management: Overview of A Practical Approach

Substance Use Disorders

PERIPHERAL NEUROPATHY. Maureen Gallagher Jesse James Maldonado

In clinical studies, gabapentin efficacy was demonstrated over a range of doses from 1800 mg/day to 3600 mg/day (1-3).

Gateshead Pain Guidelines for Chronic Conditions

PAIN INFORMATION SHEET

Avera ecare Chronic Pain Management Janell Simpkins MD, FACP Avera ecare Specialty Clinic Medical Director

Available Strengths Limits. 10 mg tablet -- $ mg tablet -- $ mg tablet -- $ mg tablet -- $72.41 Avoid use in members over

Controlled Substance and Wellness Agreement

Transcription:

Monte H. Moore, MD Idaho Physical Medicine and Rehabilitation Meridian, ID

Chronic pain brief review Opiates important things to know Factors in determining whether to use an opiate What to watch for if you decide to prescribe What to do if your patient fails to comply

Pain is the most common reason for physician consultation in the United States. It is a major symptom in many medical conditions, and can significantly interfere with a person's quality of life and general functioning.

sometimes pain persists despite removal of the stimulus and apparent healing of the body; and sometimes pain arises in the absence of any detectable stimulus, damage or disease.

3 months 6 months Pain that extends beyond the expected period of healing

Fear of injury Isolation Loss of work, $ and love, selfesteem Anxiety Depletion

Somatic or nociceptive: arthritis fracture post surgical acute musculoskeletal injuries

Central neuropathic: stroke fibromyalgia chronic pain with a strong psychological component

Peripheral neuropathic: compression neuropathy radiculopathy polyneuropathy postherpetic neuralgia phantom limb pain post amputation

May be more effective than other alternatives Low toxicity to gut, kidneys Intolerances to other drugs

Abuse potential Health risk, including death Risk of diversion Controversy regarding long term efficacy Irritating issues with patients who misuse opiates

5% of Americans over age 12 use prescription pain relievers for nonmedical purposes 70% obtain the medication from a friend or relative

Jefferson School of Population Health 2009 938,586 patients: 75% unlikely to be taking medications as prescribed 38% no detectable level of the drug prescribed 29% had a non-prescribed drug 27% had a level higher than expected 15% had a level lower than expected

Clinicians who prescribe opioids to treat chronic pain are often caught between their professional obligation to relieve suffering and their desire to avoid contributing to the non-medical consumption of controlled substances

Dependence Abstinence syndrome Tolerance Down regulation of opiate receptors Abuse Craving or Compulsion. Continued use despite adverse consequences Loss of Control

Behaviors that mimic addiction. May present in a patient with or without a history of or risk factors for drug abuse or true addiction. Often occurs in the setting of acute pain that is overlaid on a chronic pain condition. Climate of distrust and conflict between the patient and the care team related to the use of opioids for pain.

Pseudoaddiction

Neuropathic pain Significant comorbid psychopathology Long prior use of opiates (tolerance to opiates) Smoker Family history of chemical abuse

Function and quality of life will improve with a trial of increased opiates. Careful observation and knowledge of patient required

Nociceptive pain such as arthritis Psychologically stable Older patient No prior history of chemical abuse Non-smoker Negative family history of chemical abuse

Cognitive Hypotestosteronism in males and females Central sleep apnea Opioid-induced hyperalgesia

Sedation/impaired cognitive function Frequently in combination with other sedatives Patient usually unaware Family may be aware but may not see the connection or may not say anything Improves with reduction in dosage

Hypotestosteronism in males and females May be due to pituitary depletion from chronic pain Opioid suppression of GnRH in the hypothalamus Direct suppresion of testosterone production in the adrenal or gonads

Symptoms of low testosterone Lack of energy Loss of libido Depression Poor healing Diminished Opioid effects Apathy, weakness Suspect in any patient taking long term opiates Dose-related

Hypotestosteronism in males and females Reduces opioid receptor binding Treatable

Central sleep apnea Suppression of central breathing mechanism Fatigue, insomnia Reduced cognitive function Health risks of sleep apnea

Opioid-induced hyperalgesia Opioid neurotoxicity Enhanced sensitivity to painful stimuli Opioids may worsen initial pain & sensitivity to other sources of pain Often improves with opiate reduction

1. Evaluation of patient s expectations Document baseline function: Driving Cooking/cleaning Working Sleeping What does the patient want to be able to do? Are Goals realistic?

2. Is the pain likely to respond to low dose opiates? Somatic Neuropathic 3. Has there been a reasonable trial with non-opiate medications?

Nociceptive pain NSAIDs Tylenol Tramadol

Neuropathic pain Anticonvulsants Gabapentin (Neurontin) Pregabalin (Lyrica) Tiagabine (Gabitril) SNRI Venlafaxine (Effexor) Duloxetine (Cymbalta Milnacipran (Savella) Desvenlafaxine (Pristiq)

Neuropathic pain Muscle relaxers Lioresal (Baclofen) Deafferentation pain such as neuropathy or phantom limb pain Tizanidine (Zanaflex) Good for insomnia relating to neuropathic pain Tramadol Acts centrally at the opiate receptor and has potential for abuse, although less than other opiates May be effective for neuropathic pain

Neuropathic pain Tapendadol (Nucynta) Centrally acting analgesic u receptor agonist Norepinephrine uptake inhibitor Similar to hydrocodone in it s ability to relieve pain Electrical Stimulation

4. What other factors affect the pain and is there a way to address them? Deconditioning Behavioral reinforcers Depression and anxiety Smoking Testosterone Sleep disorders

physical therapy exercise injections surgery

5. Can you trust your patient? Your experience with patient Board of Pharmacy - http://ipmp.bop.idaho.gov Drug screens Other illegal activity : https://www.idcourts.us/r epository/start.do

***OPIATE RISK TOOL*** FAMILY HISTORY: - alcohol abuse M3/F1 - illegal drug use M3/F1 - prescription drug abuse M4/F4

PERSONAL HISTORY: - alcohol abuse M3/F3 - illegal drug use M4/F4 - presciption drug abuse M5/F5

MENTAL HEALTH: - Dx of ADD, OCD, bipolar, schizophrenia M2/F2 - Dx of depression M1/F1

OTHER - age 16-45 M1F1 - history of preadolescent sexual abuse M0/F3 TOTAL: SCORING: 0-3 low risk 4-7 moderate risk 8 or greater high risk

6. What are the medical risks to your patient if opiates are used? Drug interactions (other sedating medications) CNS dysfunction Sleep disturbance Liver disease Hypotestosteronism Risk of abuse and diversion

Set up clear expectations chronic pain agreement Continue to utilize non-opiates, lifestyle change, and other reasonable interventions to every extent possible Watch for drug interactions Evaluate whether the opiate is achieving the initial goals Monitor for compliance Monitor for side effects and interactions

Treat concurrent mental health disorders Be sensitive to medication costs Check for low testosterone and sleep apnea, especially if taking high doses Educate, educate, educate why you don t want to ask me to increase your dose today

Face to face conversation explaining why you aren t comfortable prescribing Refer rather than abandoning - consider referral for addiction evaluation Consider pain specialist

The challenge is to curtail the abuse and diversion of prescription opioids while ensuring their availability for patients who benefit from their use. Lynn R. Webster

The obligations to battle pain and addiction are not mutually exclusive, they are mutually inextricable Lynn R. Webster